Published in AMB Rev Assoc Med Bras on April 01, 1980
A prospective study of visceral leishmaniasis in an endemic area of Brazil. J Infect Dis (1986) 2.24
Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J Immunol (1985) 2.24
Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med (1966) 2.12
Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi. J Infect Dis (1992) 1.90
Laboratory infection with Zika virus after vaccination against yellow fever. Arch Gesamte Virusforsch (1973) 1.83
Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin. Antimicrob Agents Chemother (1981) 1.61
Renal dysfunction in Brazilian lead workers. Am J Nephrol (1987) 1.58
Comparison of bile and trypticase soy broth for isolation Salmonella from blood. Am J Clin Pathol (1966) 1.52
Leishmania donovani: an opportunistic microbe associated with progressive disease in three immunocompromised patients. Lancet (1986) 1.42
Circulating immune complexes and rheumatoid factor in schistosomiasis and visceral leishmaniasis. Am J Trop Med Hyg (1983) 1.38
Characterization of the immune response in subjects with self-healing cutaneous leishmaniasis. Am J Trop Med Hyg (1995) 1.26
Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones. Rev Infect Dis (1986) 1.14
Nephrotic syndrome in patients with Schistosoma mansoni infection. Am J Trop Med Hyg (1973) 1.13
Etiology and mortality of bacterial meningitis in northeastern Brazil. Rev Infect Dis (1990) 1.13
Renal involvement in visceral leishmaniasis. Am J Kidney Dis (1985) 1.10
Serum creatine phosphokinase in leptospirosis. JAMA (1975) 1.10
Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. J Immunol (1991) 1.09
Bacterial infections in patients with visceral leishmaniasis. J Infect Dis (1990) 1.03
Evaluation of cefamandole therapy of patients with bacterial meningitis. J Infect Dis (1978) 1.03
In vitro antibiotic susceptibility of salmonellae. Antimicrob Agents Chemother (1977) 1.01
About the "Pathological" role of the mtDNA T3308C mutationellipsis. Am J Hum Genet (1999) 1.00
A lapachol derivative active against mouse lymphocytic leukemia P-388. J Med Chem (1975) 0.99
Comparison of parenteral ampicillin and parenteral chloramphenicol in the treatment of typhoid fever. Ann N Y Acad Sci (1967) 0.98
Hyperargininemia presenting as persistent neonatal jaundice and hepatic cirrhosis. J Pediatr Gastroenterol Nutr (1997) 0.98
Schistosoma mansoni-induced mesangiocapillary glomerulonephritis: influence of therapy. Kidney Int (1989) 0.97
[Racial differences between patients with focal segmental glomerulosclerosis and membranoproliferative glomerulonephritis from the State of Bahia]. Rev Assoc Med Bras (1999) 0.97
Distribution and genetic diversity of tomato-infecting begomoviruses in Brazil. Arch Virol (2003) 0.97
Prolonged Salmonella bacteremia in patients with Schistosoma mansoni infection. Arch Intern Med (1971) 0.96
Cefamandole treatment of Salmonella bacteremia. Antimicrob Agents Chemother (1982) 0.96
Urinary concentrating ability in early experimental pyelonephritis. J Clin Invest (1970) 0.95
Schistosomal glomerulopathy. Kidney Int (1979) 0.94
Clonally related penicillin-nonsusceptible Streptococcus pneumoniae serotype 14 from cases of meningitis in Salvador, Brazil. Clin Infect Dis (2000) 0.93
Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob Agents Chemother (1985) 0.92
Visceral leishmaniasis: a disease associated with inability of lymphocytes to activate macrophages to kill leishmania. Braz J Med Biol Res (1988) 0.92
Effect of bile on the action of blood against Salmonella. J Bacteriol (1966) 0.91
[Myo-relaxant action of sodium Dantrolene in the treatment of tetanus]. Rev Inst Med Trop Sao Paulo (1976) 0.91
Experimental pyelonephritis: characteristics of infection in rats following reduction of bladder capacity. Proc Soc Exp Biol Med (1965) 0.88
Moxalactam for the treatment of bacterial meningitis in children. J Infect Dis (1983) 0.87
Experimental pyelonephritis in rats with a glass bead in the bladder. J Pathol Bacteriol (1965) 0.85
Immunological features in different clinical forms of strongyloidiasis. Trans R Soc Trop Med Hyg (1983) 0.84
Renal involvement in patients with hepatosplenic Schistosomiasis mansoni. Am J Trop Med Hyg (1976) 0.84
Tetanus as a cause of acute renal failure: possible role of rhabdomyolysis. Rev Soc Bras Med Trop (1994) 0.83
[Characteristics of Salmonella typhi infection in mice with experimental schistosomiasis: multiplication of the bacteria in Schistosoma mansoni]. Rev Inst Med Trop Sao Paulo (1972) 0.83
Mucosal leishmaniasis: quantitative nasal cytology as a marker of disease activity and indicator of healing. Ann Otol Rhinol Laryngol (2000) 0.83
The ND1 T3308C mutation may be a mtDNA polymorphism. Report of two Portuguese patients. J Inherit Metab Dis (1999) 0.83
Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr Nephrol (2001) 0.82
Evaluation of T-cell subsets in the lesion infiltrates of human cutaneous and mucocutaneous leishmaniasis. Parasite Immunol (1987) 0.82
Comparison of the complement fixation test and counterelectrophoresis test for the detection of antibodies in Chagas disease. J Clin Microbiol (1976) 0.81
[Association between race and incidence of end-stage renal disease secondary to glomerulonephritis: influence of the histologic type and presence of arterial hypertension]. Rev Assoc Med Bras (2001) 0.81
Ecto-phosphatase activities on the cell surface of the amastigote forms of Trypanosoma cruzi. Z Naturforsch C (1999) 0.80
[Clinical study of mixed infections of the urinary tract]. Hospital (Rio J) (1965) 0.80
Population genetic studies of Alouatta belzebul from the Amazonian and Atlantic Forests. Am J Primatol (2007) 0.80
[Increase in the frequency of norfloxacin and ciprofloxacin resistance of bacteria isolated from urine culture]. Rev Assoc Med Bras (1999) 0.79
[Characteristics of the inflammatory reaction in patients with hepatosplenic forms of schistosomiasis mansoni and kala-azar]. Rev Inst Med Trop Sao Paulo (1969) 0.79
Caroli's disease with congenital hepatic fibrosis and medullary sponge kidney. J Pediatr Gastroenterol Nutr (1994) 0.79
[Is glomerulopathy due to schistosomiasis mansoni disappearing?]. Rev Soc Bras Med Trop (1997) 0.78
Relapse of urinary tract infection in the presence of urinary tract calculi: the role of bacteria within the calculi. J Med Microbiol (1969) 0.78
The burden of pneumonia among children. J Trop Pediatr (2001) 0.78
Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi. Braz J Med Biol Res (1994) 0.78
Clinical course of focal segmental glomerulosclerosis associated with hepatosplenic schistosomiasis mansoni. Nephron (1995) 0.78
Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis. Am J Med (1984) 0.77
Race and glomerulonephritis in patients with and without hepatosplenic Schistosomiasis mansoni. Clin Nephrol (2002) 0.77
Value of beta 1C/1A globulin serum levels as an early index of glomerular involvement in Schistosoma mansoni infection. Am J Trop Med Hyg (1980) 0.77
Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: study of 19 heterozygous and 2 homozygous patients. Hum Mutat (1997) 0.77
Is rhabdomyolysis an additional factor in the pathogenesis of acute renal failure in leptospirosis? Rev Inst Med Trop Sao Paulo (1995) 0.77
Allergic reaction after rubber dam placement. J Endod (2000) 0.77
Renal involvement in prolonged Salmonella bacteremia: the role of schistosomal glomerulopathy. Rev Inst Med Trop Sao Paulo (1994) 0.77
Absence of clinical abnormalities suggesting renal involvement during the long-term course of visceral leishmaniasis. Rev Soc Bras Med Trop (1989) 0.77
Immune complexes in schistosomiasis. VI--Circulating IC levels in patients with and without nephropathy. Rev Inst Med Trop Sao Paulo (1980) 0.76
Clinical effects of intermittent, intravenous cyclophosphamide in severe systemic lupus erythematosus. Nephron (1996) 0.76
Community acquired pneumonia among pediatric outpatients in Salvador, Northeast Brazil, with emphasis on the role of pneumococcus. Braz J Infect Dis (2001) 0.75
[Establishment of S. typhimurium infection in mice with schistosomiasis mansoni]. Rev Inst Med Trop Sao Paulo (1973) 0.75
The influence of anti-parasitic therapy on the course of the glomerulopathy associated with Schistosomiasis mansoni. Clin Nephrol (1987) 0.75
Site of action of nitrofurantoin in experimental urinary tract infection. Appl Microbiol (1969) 0.75
[Correlations between the basic and the professional cycles]. AMB Rev Assoc Med Bras (1971) 0.75
Immunological aspects of corneal heterografts. Int Ophthalmol Clin (1966) 0.75
[Specialization versus post-graduate study]. Arq Bras Oftalmol (1967) 0.75
[Therapy of intraocular cysticercosis]. Bull Mem Soc Fr Ophtalmol (1966) 0.75
[Characteristics of E. coli infection in mice infected with Schistosoma mansoni]. Rev Inst Med Trop Sao Paulo (1969) 0.75
Pharmacokinetics of cefoperazone in normal subjects and patients with hepatosplenic schistosomiasis. J Antimicrob Chemother (1983) 0.75
[The problem of glaucoma]. Arq Bras Oftalmol (1968) 0.75
Repeated xenodiagnosis in chronic Chagas' disease: effect of a single injection of prednisolone. Rev Inst Med Trop Sao Paulo (1968) 0.75
Comparison of bile and trypticase soy broth for isolation of Salmonella from blood. Tech Bull Regist Med Technol (1966) 0.75
[Contact lenses]. Arq Bras Oftalmol (1971) 0.75
[Epidemic of food poisoning caused by Salmonella typhi-murium in the General Hospital. II. Clinical study]. Rev Inst Med Trop Sao Paulo (1966) 0.75
[Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study]. Rev Bras Pesqui Med Biol (1975) 0.75
Studies on experimental bacteremia and pyelonephritis in the marmoset (Callithrix jacchus). Proc Soc Exp Biol Med (1968) 0.75
[Medical education and full time]. AMB Rev Assoc Med Bras (1970) 0.75
[Biomicroscopy of the vitreous body and the retina]. Arq Bras Oftalmol (1967) 0.75
Comparison of bacterial counts in the urine obtained by midstream method, suprapubic needle aspiration and catheterization of the bladder in women with uterovaginal prolapse and vaginal discharge. Rev Bras Pesqui Med Biol (1974) 0.75
Experimental pyelonephritis: enhancement of infection after delivery of Escherichia coli into the arterial supply of the kidney. J Infect Dis (1969) 0.75
Elliot's operation: surgical management, complications and results. Bibl Ophthalmol (1968) 0.75
[Serum antibacterial activity of patients with the hepatosplenic form of schistosoma mansoni]. Rev Inst Med Trop Sao Paulo (1969) 0.75
Bacteriuria in apparently healthy young adults. J Urol (1969) 0.75
Cephalexin monohydrate in the treatment of urinary tract infections and urethritis. Prensa Med Mex (1971) 0.75
[Macula and fluorescein]. Arq Bras Oftalmol (1971) 0.75
[Prevention of blindness. IV. Basic training, graduate and continuing education of ophthalmologists]. Arq Bras Oftalmol (1969) 0.75
[Bacterial flora of urinary tract infections: changes in sensitivity to antibiotics over a 5 year period]. AMB Rev Assoc Med Bras (1972) 0.75